Senescence and cancer—role and therapeutic opportunities
Cellular senescence is a state of stable, terminal cell cycle arrest associated with various
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
Exploiting senescence for the treatment of cancer
L Wang, L Lankhorst, R Bernards - Nature Reviews Cancer, 2022 - nature.com
Senescence is a cellular response to a variety of stress signals that is characterized by a
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
Targeting p53 pathways: mechanisms, structures, and advances in therapy
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …
been a major focus of oncology research. The p53 protein is a transcription factor that can …
Guidelines for minimal information on cellular senescence experimentation in vivo
Cellular senescence is a cell fate triggered in response to stress and is characterized by
stable cell-cycle arrest and a hypersecretory state. It has diverse biological roles, ranging …
stable cell-cycle arrest and a hypersecretory state. It has diverse biological roles, ranging …
COVID-19 and cellular senescence
CA Schmitt, T Tchkonia, LJ Niedernhofer… - Nature Reviews …, 2023 - nature.com
The clinical severity of coronavirus disease 2019 (COVID-19) is largely determined by host
factors. Recent advances point to cellular senescence, an ageing-related switch in cellular …
factors. Recent advances point to cellular senescence, an ageing-related switch in cellular …
Cellular adaptation to cancer therapy along a resistance continuum
Advancements in precision oncology over the past decades have led to new therapeutic
interventions, but the efficacy of such treatments is generally limited by an adaptive process …
interventions, but the efficacy of such treatments is generally limited by an adaptive process …
[HTML][HTML] Drug resistance and combating drug resistance in cancer
Cancer is the second leading cause of death in the US. Current major treatments for cancer
management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy …
management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy …
Cellular senescence: aging, cancer, and injury
Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells
subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …
subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …
Therapy-induced senescence: opportunities to improve anticancer therapy
Cellular senescence is an essential tumor suppressive mechanism that prevents the
propagation of oncogenically activated, genetically unstable, and/or damaged cells …
propagation of oncogenically activated, genetically unstable, and/or damaged cells …
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Z Dong, Y Luo, Z Yuan, Y Tian, T **, F Xu - Molecular Cancer, 2024 - Springer
Cellular senescence (CS), a permanent and irreversible arrest of the cell cycle and
proliferation leading to the degeneration of cellular structure and function, has been …
proliferation leading to the degeneration of cellular structure and function, has been …